Login / Signup

Edaravone Oral Suspension: A Neuroprotective Agent to Treat Amyotrophic Lateral Sclerosis.

Priya SinghPaul BelliveauJennifer TowleAndrea Elena NeculauLorena Dima
Published in: American journal of therapeutics (2024)
Oral edaravone is an ALS treatment that can be self-administered or administered by a caregiver, precluding the need for administration by a health care professional in an institutional setting.
Keyphrases
  • amyotrophic lateral sclerosis
  • healthcare
  • combination therapy
  • blood brain barrier
  • health information
  • replacement therapy